Methods and results used in the development of a consensus-driven extension to the Consolidated Standards of Reporting Trials (CONSORT) statement for trials conducted using cohorts and routinely collected data (CONSORT-ROUTINE).
clinical trials
general medicine (see internal medicine)
statistics & research methods
Journal
BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874
Informations de publication
Date de publication:
29 04 2021
29 04 2021
Historique:
entrez:
30
4
2021
pubmed:
1
5
2021
medline:
21
5
2021
Statut:
epublish
Résumé
Randomised controlled trials conducted using cohorts and routinely collected data, including registries, electronic health records and administrative databases, are increasingly used in healthcare intervention research. A Consolidated Standards of Reporting Trials (CONSORT) statement extension for trials conducted using cohorts and routinely collected data (CONSORT-ROUTINE) has been developed with the goal of improving reporting quality. This article describes the processes and methods used to develop the extension and decisions made to arrive at the final checklist. The development process involved five stages: (1) identification of the need for a reporting guideline and project launch; (2) conduct of a scoping review to identify possible modifications to CONSORT 2010 checklist items and possible new extension items; (3) a three-round modified Delphi study involving key stakeholders to gather feedback on the checklist; (4) a consensus meeting to finalise items to be included in the extension, followed by stakeholder piloting of the checklist; and (5) publication, dissemination and implementation of the final checklist. 27 items were initially developed and rated in Delphi round 1, 13 items were rated in round 2 and 11 items were rated in round 3. Response rates for the Delphi study were 92 of 125 (74%) invited participants in round 1, 77 of 92 (84%) round 1 completers in round 2 and 62 of 77 (81%) round 2 completers in round 3. Twenty-seven members of the project team representing a variety of stakeholder groups attended the in-person consensus meeting. The final checklist includes five new items and eight modified items. The extension Explanation & Elaboration document further clarifies aspects that are important to report. Uptake of CONSORT-ROUTINE and accompanying Explanation & Elaboration document will improve conduct of trials, as well as the transparency and completeness of reporting of trials conducted using cohorts and routinely collected data.
Identifiants
pubmed: 33926985
pii: bmjopen-2021-049093
doi: 10.1136/bmjopen-2021-049093
pmc: PMC8094349
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
e049093Subventions
Organisme : CIHR
ID : PJT156172
Pays : Canada
Organisme : Wellcome Trust
ID : 205039/Z/16/Z
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/N008405/1
Pays : United Kingdom
Organisme : CIHR
Pays : Canada
Organisme : CIHR
ID : PCS-161863
Pays : Canada
Organisme : Wellcome Trust
Pays : United Kingdom
Informations de copyright
© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
J Clin Epidemiol. 2016 Nov;79:104-111
pubmed: 27343981
BMJ. 2010 Mar 23;340:c332
pubmed: 20332509
Cochrane Database Syst Rev. 2012 Nov 14;11:MR000030
pubmed: 23152285
BMJ Open. 2018 Aug 5;8(8):e025266
pubmed: 30082372
Health Technol Assess. 2014 Jul;18(43):1-146
pubmed: 25011568
BMJ. 2015 May 14;350:h1738
pubmed: 25976398
BMJ. 2011 Nov 22;343:d6783
pubmed: 22108262
BMJ. 2021 Apr 29;373:n857
pubmed: 33926904
PLoS Med. 2010 Feb 16;7(2):e1000217
pubmed: 20169112
BMJ. 2010 Mar 19;340:c1066
pubmed: 20304934
Shock. 2017 Oct;48(4):436-440
pubmed: 28328711
BMJ. 2008 Nov 11;337:a2390
pubmed: 19001484
J Public Health (Oxf). 2007 Dec;29(4):463-71
pubmed: 17942850
Res Integr Peer Rev. 2018 Oct 29;3:9
pubmed: 30397513
BMJ. 2007 Oct 20;335(7624):806-8
pubmed: 17947786
Clin Trials. 2016 Oct;13(5):519-26
pubmed: 27365013
PLoS Med. 2015 Oct 06;12(10):e1001885
pubmed: 26440803
BMJ. 2016 Oct 24;355:i5239
pubmed: 27777223
Heart. 2012 Sep;98(18):1329-31
pubmed: 22591738
JAMA. 2001 Apr 18;285(15):1992-5
pubmed: 11308436
BMC Infect Dis. 2016 Aug 17;16:421
pubmed: 27530528
J Adv Nurs. 2000 Oct;32(4):1008-15
pubmed: 11095242
Int J Surg. 2016 Dec;36(Pt A):319-323
pubmed: 27770639
Curr Cardiol Rep. 2016 Jan;18(1):11
pubmed: 26758999
CMAJ Open. 2019 Feb 3;7(1):E23-E32
pubmed: 30718353
Nat Rev Cardiol. 2015 May;12(5):312-6
pubmed: 25781411
BMJ. 2004 Mar 20;328(7441):702-8
pubmed: 15031246
Am J Gastroenterol. 2013 Aug;108(8):1231-5
pubmed: 23912401
JAMA. 2019 Apr 23;321(16):1610-1620
pubmed: 31012939